NCT04428502View on ClinicalTrials.gov

Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

July 5, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Psoriatic Arthritis
Interventions
DRUG

Enbrel

As provided in real world practice

Trial Locations (1)

Unknown

Pfizer, Baghdad

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY